Maxcyte (MXCT) Long-Term Debt Issuances (2021)
Maxcyte (MXCT) posted quarterly Long-Term Debt Issuances of $4.9 million for Q1 2021.
Maxcyte (MXCT) Long-Term Debt Issuances (2021) Analysis & Trends
Maxcyte (MXCT) has reported Long-Term Debt Issuances for 1 consecutive years, with $4.9 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Long-Term Debt Issuances changed N/A year-over-year to $4.9 million; the TTM figure through Dec 2021 stood at $4.9 million (changed N/A YoY), while the FY2021 annual figure was $4.9 million, up 241.83% from the prior year.
- Long-Term Debt Issuances steadied at $4.9 million in Q1 2021 per MXCT's latest filing.
- Across five years, Long-Term Debt Issuances topped out at $4.9 million in Q1 2021 and bottomed at $4.9 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -33.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 109.26 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 4.92 Mn |
| Mar 31, 2021 | 4.92 Mn |